Next Article in Journal / Special Issue
Is Five Percent Too Small? Analysis of the Overlaps between Disorder, Coiled Coil and Collagen Predictions in Complete Proteomes
Previous Article in Journal / Special Issue
Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004–2013
Proteomes 2014, 2(1), 53-71; doi:10.3390/proteomes2010053

Proteomic Applications in the Study of Human Mesenchymal Stem Cells

, 2,3
, 2,3
, 1,2,4
 and 2,3,*
Received: 4 December 2013; in revised form: 15 January 2014 / Accepted: 26 January 2014 / Published: 7 February 2014
(This article belongs to the Special Issue Feature Paper 2013)
View Full-Text   |   Download PDF [723 KB, uploaded 7 February 2014]   |   Browse Figure
Abstract: Mesenchymal stem cells (MSCs) are undifferentiated cells with an unlimited capacity for self-renewal and able to differentiate towards specific lineages under appropriate conditions. MSCs are, a priori, a good target for cell therapy and clinical trials as an alternative to embryonic stem cells, avoiding ethical problems and the chance for malignant transformation in the host. However, regarding MSCs, several biological implications must be solved before their application in cell therapy, such as safe ex vivo expansion and manipulation to obtain an extensive cell quantity amplification number for use in the host without risk accumulation of genetic and epigenetic abnormalities. Cell surface markers for direct characterization of MSCs remain unknown, and the precise molecular mechanisms whereby growth factors stimulate their differentiation are still missing. In the last decade, quantitative proteomics has emerged as a promising set of techniques to address these questions, the answers to which will determine whether MSCs retain their potential for use in cell therapy. Proteomics provides tools to globally analyze cellular activity at the protein level. This proteomic profiling allows the elucidation of connections between broad cellular pathways and molecules that were previously impossible to determine using only traditional biochemical analysis. However; thus far, the results obtained must be orthogonally validated with other approaches. This review will focus on how these techniques have been applied in the evaluation of MSCs for their future applications in safe therapies.
Keywords: mesenchymal stem cell; proteomic analysis; characterization; differentiation mesenchymal stem cell; proteomic analysis; characterization; differentiation
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Mateos, J.; Pernas, P.F.; Labora, J.F.; Blanco, F.; Arufe, M.C. Proteomic Applications in the Study of Human Mesenchymal Stem Cells. Proteomes 2014, 2, 53-71.

AMA Style

Mateos J, Pernas PF, Labora JF, Blanco F, Arufe MC. Proteomic Applications in the Study of Human Mesenchymal Stem Cells. Proteomes. 2014; 2(1):53-71.

Chicago/Turabian Style

Mateos, Jesús; Pernas, Pablo F.; Labora, Juan F.; Blanco, Francisco; Arufe, María C. 2014. "Proteomic Applications in the Study of Human Mesenchymal Stem Cells." Proteomes 2, no. 1: 53-71.

Proteomes EISSN 2227-7382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert